p.88 抽出テキスト
549. Datt V, Wadhhwa R, Sharma V, Virmani S, Minhas HS, Malik S. Vasoplegic syndrome after cardiovascular surgery: a review of pathophysiology and outcome-oriented therapeutic management. J Card Surg 2021;36:3749–3760. https://doi.org/10.1111/ jocs.15805 550. Grayling M, Deakin CD. Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis. J Thorac Cardiovasc Surg 2003;125: 426–427. https://doi.org/10.1067/mtc.2003.140 551. Santer D, Miazza J, Koechlin L, Gahl B, Rrahmani B, Hollinger A, et al. Hemoadsorption during cardiopulmonary bypass in patients with endocarditis undergoing valve surgery: a retrospective single-center study. J Clin Med 2021;10:564. https://doi.org/10.3390/ jcm10040564 552. Diab M, Lehmann T, Bothe W, Akhyari P, Platzer S, Wendt D, et al. Cytokine hemoadsorption during cardiac surgery versus standard surgical care for infective endocarditis (REMOVE): results from a multicenter randomized controlled trial. Circulation 2022; 145:959–968. https://doi.org/10.1161/CIRCULATIONAHA.121.056940 553. Pettersson GB, Hussain ST, Shrestha NK, Gordon S, Fraser TG, Ibrahim KS, et al. Infective endocarditis: an atlas of disease progression for describing, staging, coding, and understanding the pathology. J Thorac Cardiovasc Surg 2014;147:1142–1149.e2. https://doi.org/10.1016/j.jtcvs.2013.11.031 554. de Kerchove L, Vanoverschelde JL, Poncelet A, Glineur D, Rubay J, Zech F, et al. Reconstructive surgery in active mitral valve endocarditis: feasibility, safety and durability. Eur J Cardiothorac Surg 2007;31:592–599. https://doi.org/10.1016/j.ejcts.2007.01. 002 555. Defauw RJ, Tomsic A, van Brakel TJ, Marsan NA, Klautz RJM, Palmen M. A structured approach to native mitral valve infective endocarditis: is repair better than replacement? Eur J Cardiothorac Surg 2020;58:544–550. https://doi.org/10.1093/ejcts/ezaa079 556. Toyoda N, Itagaki S, Egorova NN, Tannous H, Anyanwu AC, El-Eshmawi A, et al. Real-world outcomes of surgery for native mitral valve endocarditis. J Thorac Cardiovasc Surg 2017;154:1906–1912.e9. https://doi.org/10.1016/j.jtcvs.2017.07.077 557. Witten JC, Houghtaling PL, Shrestha NK, Gordon SM, Jaber W, Blackstone EH, et al. Aortic allograft infection risk. J Thorac Cardiovasc Surg 2023;165:1303–1315.e9. https:// doi.org/10.1016/j.jtcvs.2021.04.086 558. Witten JC, Durbak E, Houghtaling PL, Unai S, Roselli EE, Bakaeen FG, et al. Performance and durability of cryopreserved allograft aortic valve replacements. Ann Thorac Surg 2021;111:1893–1900. https://doi.org/10.1016/j.athoracsur.2020.07. 033 559. Flynn CD, Curran NP, Chan S, Zegri-Reiriz I, Tauron M, Tian DH, et al. Systematic review and meta-analysis of surgical outcomes comparing mechanical valve replacement and bioprosthetic valve replacement in infective endocarditis. Ann Cardiothorac Surg 2019;8:587–599. https://doi.org/10.21037/acs.2019.10.03 560. Giambuzzi I, Bonalumi G, Di Mauro M, Roberto M, Corona S, Alamanni F, et al. Surgical aortic mitral curtain replacement: systematic review and metanalysis of early and longterm results. J Clin Med 2021;10:3163. https://doi.org/10.3390/jcm10143163 561. Murphy KM, Vikram HR. Heart transplantation for infective endocarditis: viable option for a limited few? Transpl Infect Dis 2019;21:e13006. https://doi.org/10.1111/tid.13006 562. Nappi F, Singh SSA, Spadaccio C, Acar C. Revisiting the guidelines and choice the ideal substitute for aortic valve endocarditis. Ann Transl Med 2020;8:952. https://doi.org/10. 21037/atm-20-1522 563. Head SJ, Celik M, Kappetein AP. Mechanical versus bioprosthetic aortic valve replacement. Eur Heart J 2017;38:2183–2191. https://doi.org/10.1093/eurheartj/ehx141 564. AATS Surgical Treatment of Infective Endocarditis Consensus Guidelines Writing Committee Chairs; Pettersson GB, Coselli JS, Writing C, Pettersson GB, Coselli JS, et al. 2016 the American Association for thoracic surgery (AATS) consensus guidelines: surgical treatment of infective endocarditis: executive summary. J Thorac Cardiovasc Surg 2017;153:1241–1258.e29. https://doi.org/10.1016/j.jtcvs.2016.09.093 565. Delahaye F, Chu VH, Altclas J, Barsic B, Delahaye A, Freiberger T, et al. One-year outcome following biological or mechanical valve replacement for infective endocarditis. Int J Cardiol 2015;178:117–123. https://doi.org/10.1016/j.ijcard.2014.10.125 566. Cahill TJ, Baddour LM, Habib G, Hoen B, Salaun E, Pettersson GB, et al. Challenges in infective endocarditis. J Am Coll Cardiol 2017;69:325–344. https://doi.org/10.1016/j.jacc. 2016.10.066 567. Samura T, Yoshioka D, Toda K, Sakaniwa R, Yokoyama J, Suzuki K, et al. Emergency valve surgery improves clinical results in patients with infective endocarditis complicated with acute cerebral infarction: analysis using propensity score matchingdagger. Eur J Cardiothorac Surg 2019;56:942–949. https://doi.org/10.1093/ejcts/ezz100 568. Bonaros N, Czerny M, Pfausler B, Muller S, Bartel T, Thielmann M, et al. Infective endocarditis and neurologic events: indications and timing for surgical interventions. Eur Heart J Suppl 2020;22(Suppl M):M19–M25. https://doi.org/10.1093/eurheartj/suaa167 569. Barsic B, Dickerman S, Krajinovic V, Pappas P, Altclas J, Carosi G, et al. Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke. Clin Infect Dis 2013;56:209–217. https://doi.org/10.1093/cid/cis878 570. Suzuki M, Takanashi S, Ohshima Y, Nagatomo Y, Seki A, Takamisawa I, et al. Critical potential of early cardiac surgery for infective endocarditis with cardio-embolic strokes. Int J Cardiol 2017;227:222–224. https://doi.org/10.1016/j.ijcard.2016.11.143 571. Okita Y, Minakata K, Yasuno S, Uozumi R, Sato T, Ueshima K, et al. Optimal timing of surgery for active infective endocarditis with cerebral complications: a Japanese multicentre study. Eur J Cardiothorac Surg 2016;50:374–382. https://doi.org/10.1093/ ejcts/ezw035 572. Arregle F, Martel H, Philip M, Gouriet F, Casalta JP, Riberi A, et al. Infective endocarditis with neurological complications: delaying cardiac surgery is associated with worse outcome. Arch Cardiovasc Dis 2021;114:527–536. https://doi.org/10.1016/j.acvd.2021.01. 004 573. Matthews CR, Hartman T, Madison M, Villelli NW, Namburi N, Colgate CL, et al. Preoperative stroke before cardiac surgery does not increase risk of postoperative stroke. Sci Rep 2021;11:9025. https://doi.org/10.1038/s41598-021-88441-y 574. Murai R, Kaji S, Kitai T, Kim K, Ota M, Koyama T, et al. The clinical significance of cerebral microbleeds in infective endocarditis patients. Semin Thorac Cardiovasc Surg 2019; 31:51–58. https://doi.org/10.1053/j.semtcvs.2018.09.020 575. Ruttmann E, Abfalterer H, Wagner J, Grimm M, Muller L, Bates K, et al. Endocarditis-related stroke is not a contraindication for early cardiac surgery: an investigation among 440 patients with left-sided endocarditis. Eur J Cardiothorac Surg 2020; 58:1161–1167. https://doi.org/10.1093/ejcts/ezaa239 576. Small CN, Laurent D, Lucke-Wold B, Goutnik MA, Yue S, Chalouhi N, et al. Timing surgery and hemorrhagic complications in endocarditis with concomitant cerebral complications. Clin Neurol Neurosurg 2022;214:107171. https://doi.org/10.1016/j. clineuro.2022.107171 577. Tam DY, Yanagawa B, Verma S, Ruel M, Fremes SE, Mazine A, et al. Early vs late surgery for patients with endocarditis and neurological injury: a systematic review and meta-analysis. Can J Cardiol 2018;34:1185–1199. https://doi.org/10.1016/j.cjca.2018. 05.010 578. Zhang LQ, Cho S-M, Rice CJ, Khoury J, Marquardt RJ, Buletko AB, et al. Valve surgery for infective endocarditis complicated by stroke: surgical timing and perioperative neurological complications. Eur J Neurol 2020;27:2430–2438. https://doi.org/10. 1111/ene.14438 579. Jiad E, Gill SK, Krutikov M, Turner D, Parkinson MH, Curtis C, et al. When the heart rules the head: ischaemic stroke and intracerebral haemorrhage complicating infective endocarditis. Pract Neurol 2017;17:28–34. https://doi.org/10.1136/practneurol-2016- 001469 580. Misfeld M, Girrbach F, Etz CD, Binner C, Aspern KV, Dohmen PM, et al. Surgery for infective endocarditis complicated by cerebral embolism: a consecutive series of 375 patients. J Thorac Cardiovasc Surg 2014;147:1837–1844. https://doi.org/10.1016/j. jtcvs.2013.10.076 581. Kume Y, Fujita T, Fukushima S, Shimahara Y, Matsumoto Y, Yamashita K, et al. Intracranial mycotic aneurysm is associated with cerebral bleeding post-valve surgery for infective endocarditis. Interact Cardiovasc Thorac Surg 2018;27:635–641. https://doi. org/10.1093/icvts/ivy126 582. Salaun E, Touil A, Hubert S, Casalta JP, Gouriet F, Robinet-Borgomano E, et al. Intracranial haemorrhage in infective endocarditis. Arch Cardiovasc Dis 2018;111: 712–721. https://doi.org/10.1016/j.acvd.2018.03.009 583. Musleh R, Schlattmann P, Caldonazo T, Kirov H, Witte OW, Doenst T, et al. Surgical timing in patients with infective endocarditis and with intracranial hemorrhage: a systematic review and meta-analysis. J Am Heart Assoc 2022;11:e024401. https://doi.org/ 10.1161/JAHA.121.024401 584. Yoshioka D, Toda K, Sakaguchi T, Okazaki S, Yamauchi T, Miyagawa S, et al. Valve surgery in active endocarditis patients complicated by intracranial haemorrhage: the influence of the timing of surgery on neurological outcomes. Eur J Cardiothorac Surg 2014; 45:1082–1088. https://doi.org/10.1093/ejcts/ezt547 585. Manne MB, Shrestha NK, Lytle BW, Nowicki ER, Blackstone E, Gordon SM, et al. Outcomes after surgical treatment of native and prosthetic valve infective endocarditis. Ann Thorac Surg 2012;93:489–493. https://doi.org/10.1016/j.athoracsur.2011.10. 063 586. Wang A, Chu VH, Athan E, Delahaye F, Freiberger T, Lamas C, et al. Association between the timing of surgery for complicated, left-sided infective endocarditis and survival. Am Heart J 2019;210:108–116. https://doi.org/10.1016/j.ahj.2019.01.004 587. Champey J, Pavese P, Bouvaist H, Kastler A, Krainik A, Francois P. Value of brain MRI in infective endocarditis: a narrative literature review. Eur J Clin Microbiol Infect Dis 2016; 35:159–168. https://doi.org/10.1007/s10096-015-2523-6 588. Martinez-Selles M, Munoz P, Estevez A, del Castillo R, Garcia-Fernandez MA, Rodriguez-Creixems M, et al. Long-term outcome of infective endocarditis in nonintravenous drug users. Mayo Clin Proc 2008;83:1213–1217. https://doi.org/10.4065/ 83.11.1213 589. Thuny F, Giorgi R, Habachi R, Ansaldi S, Le Dolley Y, Casalta JP, et al. Excess mortality and morbidity in patients surviving infective endocarditis. Am Heart J 2012;164: 94–101. https://doi.org/10.1016/j.ahj.2012.04.003 590. Agrawal A, Virk HUH, Riaz I, Jain D, Tripathi B, Krittanawong C, et al. Predictors of 30-day re-admissions in patients with infective endocarditis: a national population based cohort study. Rev Cardiovasc Med 2020;21:123–127. https://doi.org/10.31083/ j.rcm.2020.01.552 591. Alagna L, Park LP, Nicholson BP, Keiger AJ, Strahilevitz J, Morris A, et al. Repeat endocarditis: analysis of risk factors based on the International Collaboration on Endocarditis – prospective cohort study. Clin Microbiol Infect 2014;20:566–575. https://doi.org/10.1111/1469-0691.12395 ESC Guidelines 4035 Downloaded from academic.oup.com/eurheartj/article/44/39/3948/7243107 by guest on 07 October 2026